Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.52 |
| ▸ | BCHE | P06276 | 9/20 | 0.38 |
| ▸ | ACHE | P22303 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21726598 | 0.87 | SIGMAR1 (0.46) | SIGMAR1BCHEACHECYP1A2 | |
| SCHEMBL19681593 | 0.84 | SIGMAR1 (0.68) | SIGMAR1BCHEACHECYP1A2L3MBTL1 | |
| SCHEMBL6624957 | 0.84 | SIGMAR1 (0.68) | SIGMAR1BCHEACHECYP1A2L3MBTL1 | |
| Water SCHEMBL31169614 | 0.82 | SIGMAR1 (0.65) | SIGMAR1BCHEACHECYP1A2L3MBTL1 | |
| SCHEMBL8039198 | 0.82 | SIGMAR1 (0.64) | SIGMAR1BCHEACHECYP1A2L3MBTL1 | |
| SCHEMBL28402059 | 0.75 | SIGMAR1 (0.57) | SIGMAR1BCHEACHECYP1A2L3MBTL1 | |
| SCHEMBL18968071 | 0.72 | — | — | |
| SCHEMBL24595495 | 0.71 | SIGMAR1 (0.83) | SIGMAR1CYP1A2L3MBTL1 | |
| SCHEMBL173002 | 0.71 | SIGMAR1 (0.83) | SIGMAR1CYP1A2L3MBTL1 | |
| SCHEMBL19681594 | 0.71 | SIGMAR1 (0.83) | SIGMAR1CYP1A2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10562849-B2 | Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10562849-B2 | Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids | ABHD16A, AARS1, CFTR | SIGMAR1 1671/4885BCHE 3535/4885ACHE 4853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.